Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia

被引:2
|
作者
Alkhatabi, Heba [1 ,2 ]
Bin Saddeq, Haneen Abdulfattah [3 ]
Alyamani, Luay [4 ]
Shinawi, Thoraia [1 ]
Yasin, Elrashed B. [5 ]
Alserihi, Raed [1 ,6 ]
Felimban, Raed [1 ,6 ]
Tayeb, Hossam H. [1 ,6 ]
Mimani, Rawan [2 ]
Alalla, Zainab [2 ]
Abu-Elmagd, Muhammad [2 ]
Abuzenadah, Adel [1 ,7 ]
机构
[1] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah 80200, Saudi Arabia
[2] King Abdulaziz Univ, Ctr Excellence Genom Med Res CEGMR, Jeddah 80200, Saudi Arabia
[3] King Abdullah Med City, Mecca 24246, Saudi Arabia
[4] King Saud Bin Abdelaziz Univ Hlth Sci, Coll Med, Basic Med Sci Dept, Jeddah 80200, Saudi Arabia
[5] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Rabigh 25732, Saudi Arabia
[6] King Abdulaziz Univ, Ctr Innovat Personalized Med CIPM, Jeddah 80200, Saudi Arabia
[7] King Abdulaziz Univ, King Fahad Med Res Ctr KFMRC, Jeddah 80200, Saudi Arabia
关键词
IDH1; IDH2; AML; ALL; ACUTE MYELOID-LEUKEMIA; IDH2; MUTATIONS; FREQUENCY;
D O I
10.3390/genes12121963
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Different forms of human cancer show mutations for isocitrate dehydrogenases 1 and 2 (IDH1/2). Mutation of these genes can cause aberrant methylation of the genome CpG islands (CGIs), which leads to an increase of suppressed oncogenes transcription or repression of active tumor suppressor gene transcription. This study aimed to identify the prevalence of IDH1/2 mutations in acute leukemia patients. The study cohort included 43 AML patients and 30 childhood ALL patients, from whom DNA bone marrow samples were taken. The alteration hotspots in codons IDH1 (R132) and IDH2 (R172 and R140) were examined via direct sequencing. Mutations in IDH1 were detected in 7 out of 43 (16.2%) AML patients; 5 of them occurred at codon R132. The other two mutations included a single-nucleotide polymorphism, which affected codon G105 in one patient. However, no mutation was detected in the IDH2 in any of the patients. Moreover, no mutations were detected in either IDH1 or IDH2 in ALL patients. The dominance of IDH1 mutations in AML, which was 16%, emphasizes the existence of the mutation in our population. On the other hand, IDH2 mutation was observed to be less frequent in both illnesses. Due to the limitation of using a small sample size, larger cohort screening is recommended to determine their usefulness as prognostic indicators.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma
    Taher, Mohiuddin M.
    Dairi, Ghida
    Butt, Ejaz Muhammad
    Al-Quthami, Khalid
    Al-Khalidi, Hisham
    Jastania, Raid A.
    Nageeti, Tahani H.
    Bogari, Neda M.
    Athar, Mohammad
    Al-Allaf, Faisal A.
    Valerie, Kristoffer
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [42] Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
    Boutzen, Helena
    Saland, Estelle
    Larrue, Clement
    de Toni, Fabienne
    Gales, Lara
    Castelli, Florence A.
    Cathebas, Mathilde
    Zaghdoudi, Sonia
    Stuani, Lucille
    Kaoma, Tony
    Riscal, Romain
    Yang, Guangli
    Hirsch, Pierre
    David, Marion
    De Mas-Mansat, Veronique
    Delabesse, Eric
    Vallar, Laurent
    Delhommeau, Francois
    Jouanin, Isabelle
    Ouerfelli, Ouathek
    Le Cam, Laurent
    Linares, Laetitia K.
    Junot, Christophe
    Portais, Jean-Charles
    Vergez, Francois
    Recher, Christian
    Sarry, Jean-Emmanuel
    JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (04) : 483 - 497
  • [43] Mutations Encountered in Acute Lymphoblastic Leukemia: A Retrospective Study in a Teaching Hospital in Jeddah, Saudi Arabia
    Qari, Mohamad H.
    Alattas, Ali Alawi
    Binkuddah, Sultan Mohammed
    Almarri, Abdullah K.
    Shafy, Suhayb
    Alsulami, Salem Khalifah
    Alzuhayri, Jumana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [44] Application of denaturing capillary electrophoresis for the detection of prognostic mutations in isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 genes in brain tumors
    Benesova, Lucie
    Belsanova, Barbora
    Kramar, Filip
    Halkova, Tereza
    Benes, Vladimir
    Minarik, Marek
    JOURNAL OF SEPARATION SCIENCE, 2018, 41 (13) : 2819 - 2827
  • [45] Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas
    Sim, Hao-Wen
    Nejad, Romina
    Zhang, Wenjiang
    Nassiri, Farshad
    Mason, Warren
    Aldape, Kenneth D.
    Zadeh, Gelareh
    Chen, Eric X.
    CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3366 - 3373
  • [46] Role of isocitrate dehydrogenase 1/2 (IDH 1/2) gene mutations in human tumors
    Liu, Xiang
    Ling, Zhi-Qiang
    HISTOLOGY AND HISTOPATHOLOGY, 2015, 30 (10) : 1155 - 1160
  • [47] Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia
    Willander K.
    Falk I.J.
    Chaireti R.
    Paul E.
    Hermansson M.
    Gréen H.
    Lotfi K.
    Söderkvist P.
    Biomarker Research, 2 (1)
  • [48] Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism
    Reitman, Zachary J.
    Yan, Hai
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13): : 932 - 941
  • [49] Biological Microarray for Detection of Somatic Mutations in the Genes of Isocitrate Dehydrogenase 1 and 2
    V. O. Varachev
    D. A. Guskov
    A. P. Shekhtman
    D. V. Rogozhin
    S. A. Polyakov
    A. S. Zacedatelev
    A. V. Chudinov
    T. V. Nasedkina
    Russian Journal of Bioorganic Chemistry, 2023, 49 : 1137 - 1142
  • [50] Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations
    Toth, Laura N.
    de Abreu, Francine B.
    Tafe, Laura J.
    HUMAN PATHOLOGY, 2018, 78 : 138 - 143